World's Best Scientists 2026 revealed!
Blood Cells, Molecules, and Diseases
H-index 11

Blood Cells, Molecules, and Diseases

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Biology and Biochemistry 602 27 42 9
Medicine 2212 39 44 11

Additional Metrics

Number of Best Scientists*: 86
Documents by Best Scientists*: 77
Top 100 Ranked Scientists*: 6
SCIMAGO H-index: 100
SCIMAGO SJR: 0.633
Impact Factor: 1.7

Overview

Top Research Topics at Blood Cells Molecules and Diseases?

Internal medicine, Molecular biology, Immunology, Genetics and Cell biology are among the topics commonly tackled in Blood Cells Molecules and Diseases. In addition to Internal medicine research, Blood Cells Molecules and Diseases aims to explore topics under Gastroenterology, Endocrinology, Surgery and Oncology. The journal explores research in Molecular biology alongside concepts in Biochemistry and other areas of study in Biophysics.

The research on Immunology featured in Blood Cells Molecules and Diseases combines topics in other fields like Cancer research, Stem cell and Anemia. The work on Stem cell addressed in the journal expands to the thematically related Transplantation. As a part of Blood Cells Molecules and Diseases, discussions in Genetics involve topics like Gene, Mutation, Allele, Genotype and Exon.

The works on Cell biology deal in particular with Haematopoiesis. The journal explores research in Haematopoiesis and the adjacent study of Progenitor cell. Enzyme replacement therapy is part of Disease studies tackled in the journal.

  • Internal medicine (20.75%)
  • Molecular biology (19.66%)
  • Immunology (19.44%)

What are the most cited papers published in the journal?

  • The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. (404 citations)
  • Mutation Analysis in Hereditary Hemochromatosis (377 citations)
  • Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region. (333 citations)

Research areas of the most cited articles at Blood Cells Molecules and Diseases:

The most cited publications mainly deal with areas of study such as Immunology, Internal medicine, Genetics, Cell biology and Molecular biology. In addition to Immunology research, the journal publications aim to explore topics under Cytotoxic T cell and Anemia. The journal articles address concerns in Internal medicine which are intertwined with other disciplines, such as Gastroenterology, Endocrinology and Surgery.

What topics the last edition of the journal is best known for?

  • Gene
  • Internal medicine
  • Enzyme

The previous edition focused in particular on these issues:

The journal tackles a plethora of topics, such as Internal medicine, Cancer research, Gastroenterology, Disease and Immunology. The studies in Internal medicine featured incorporate elements of Diamond–Blackfan anemia and Oncology. Topics in Cancer research explored in it were investigated in conjunction with research in Progenitor cell, Haematopoiesis, Epigenetics and Bone marrow.

Blood Cells Molecules and Diseases holds forums on Gastroenterology that merges themes from other disciplines such as Hemoglobin, Inflammation, Tolerability, Single Center and Thrombosis. The journal focuses on Disease but the discussions also offer insight into other areas such as Cell, Clinical trial and Incidence (epidemiology). Issues in Cell were discussed, taking into consideration concepts from other disciplines like Platelet and Cell biology.

The most cited articles from the last journal are:

  • Effectiveness of convalescent plasma in Indian patients with COVID-19. (15 citations)
  • Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies. (9 citations)
  • Is the erythropoietin-erythroferrone-hepcidin axis intact in human neonates? (5 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Blood Cells Molecules and Diseases (based on the number of publications) are:

  • Ari Zimran (63 papers) absent at the last edition,
  • Ernest Beutler (62 papers) absent at the last edition,
  • Deborah Elstein (41 papers) absent at the last edition,
  • Pauline Lee (25 papers) absent at the last edition,
  • Terri Gelbart (24 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Blood Cells Molecules and Diseases (based on the number of publications) are:

  • Scripps Research Institute (97 papers) absent at the last edition,
  • Boston Children's Hospital (92 papers) published 6 papers at the last edition, 3 more than at the previous edition,
  • Shaare Zedek Medical Center (67 papers) absent at the last edition,
  • National Institutes of Health (63 papers) published 3 papers at the last edition, 2 more than at the previous edition,
  • French Institute of Health and Medical Research (60 papers) published 2 papers at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 5.06% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 24.00% were posted by at least one author from the top 10 institutions publishing in the journal. Another 9.33% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 16.00% of all publications and 50.67% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Hematologically important mutations: X-linked chronic granulomatous disease (fourth update).

    (2021)
    46 Citations
  • Hematologically important mutations: The autosomal forms of chronic granulomatous disease (third update).

    Dirk Roos;Karin van Leeuwen;Amy P. Hsu;Debra Long Priel

    (2021)
    32 Citations
  • Mitapivat increases ATP and decreases oxidative stress and erythrocyte mitochondria retention in a SCD mouse model.

    (2022)
    28 Citations
  • A case of VEXAS syndrome associated with EBV-associated hemophagocytic lymphohistiocytosis

    Roy L. Kao;Audrey A. Jacobsen;Charles J. Billington;Sophia L. Yohe

    (2022)
    23 Citations
  • Hematologically important mutations: Leukocyte adhesion deficiency (second update).

    (2023)
    21 Citations
  • Splenectomy and the incidence of venous thromboembolism and sepsis in patients with autoimmune hemolytic anemia.

    Gwendolyn Ho;Gwendolyn Ho;Ann Brunson;Theresa H.M. Keegan;Ted Wun

    (2020)
    20 Citations
  • Is the erythropoietin-erythroferrone-hepcidin axis intact in human neonates?

    Timothy M. Bahr;Diane M. Ward;Xuan Jia;Robin K. Ohls

    (2021)
    18 Citations

Related Online Degrees & Career Pathways

For students interested in healthcare but not pursuing traditional medical school, several alternative career paths and online degrees offer flexibility and accelerated programs. Many registered nurses seek advancement through programs like rn to bsn in 6 months, allowing them to elevate their qualifications quickly and open doors to leadership roles.

For those aiming to become nurse practitioners, understanding how many years does it take to be a nurse practitioner is crucial for planning an efficient career path. Accelerated options, such as adn to fnp programs, help nurses transition from associate degrees to family nurse practitioners with focused training.

Additionally, direct-entry MSN programs can be ideal for individuals without a nursing background. These online direct entry msn programs provide a fast-track route to master's-level nursing qualifications, enabling a smooth shift into advanced nursing roles.

Exploring these related degrees and pathways can offer practical alternatives for those passionate about healthcare, allowing diverse opportunities to contribute to patient care beyond traditional medical degrees.

Best Scientists Contributing to This Journal